Radiolabeled Iron Oxide Nanoparticles As Dual-Modality SPECT/MRI and PET/MRI Agents

Author(s): Penelope Bouziotis, Dimitrios Psimadas, Theodoros Tsotakos, Dimosthenis Stamopoulos, Charalampos Tsoukalas

Journal Name: Current Topics in Medicinal Chemistry

Volume 12 , Issue 23 , 2012


Become EABM
Become Reviewer
Call for Editor

Abstract:

Dual-modality contrast agents, such as radiolabeled nanoparticles, are promising candidates for a number of diagnostic applications, since they combine the advantages of two different imaging modalities, namely SPECT or PET imaging with MR imaging. The benefit of such a combination is to more accurately interpret disease and abnormalities in vivo, by exploiting the advantages of each imaging technique, i.e. high sensitivity for SPECT/PET, high resolution anatomical information for MRI. In this review article, we provide an overview of recent findings in the synthesis, evaluation and application of radiolabeled iron oxide nanoparticles as dual-modality SPECT/MRI and PET/MRI imaging probes.

Keywords: Magnetic nanoparticles, iron oxide, radiolabeling, dual modality imaging, SPECT/MRI, PET/MRI

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 12
ISSUE: 23
Year: 2012
Published on: 08 March, 2013
Page: [2694 - 2702]
Pages: 9
DOI: 10.2174/1568026611212230007
Price: $65

Article Metrics

PDF: 39